Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12611000147987
Ethics application status
Approved
Date submitted
4/02/2011
Date registered
8/02/2011
Date last updated
9/07/2019
Date data sharing statement initially provided
9/07/2019
Date results provided
9/07/2019
Type of registration
Prospectively registered

Titles & IDs
Public title
Comparison study of two different techniques for knee replacement
Scientific title
In patients with osteoarthritis of the knee, are patient specific cutting guides used for total knee joint replacement as good as computer-assisted surgery for patient outcomes?
Secondary ID [1] 253423 0
ShapeMatchNZRCT-10
Universal Trial Number (UTN)
U1111-1119-0601
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Osteoarthritis of the knee 260969 0
Condition category
Condition code
Musculoskeletal 259106 259106 0 0
Osteoarthritis
Surgery 259280 259280 0 0
Surgical techniques

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
For patients requiring a total knee replacement a new method has been developed which may improve patient satisfaction levels in terms of function and pain after surgery. Instead of using conventional measuring and cutting equipment and computer-assisted navigation (Control Group), patient-specific cutting guides will be manufactured based on pre-operative Magnetic Resonance Imaging (MRI) scans of the patient's leg (Intervention Group). The patient will have a total knee replacement performed using these cutting guides which will ultimately align the patient’s prosthesis according to their natural leg alignment (as opposed to the convention way where the patient’s leg is aligned according to a mechanical axis of 0 degrees). The procedure will take approximately 45 minutes.
Both groups will receive the same type of implant. Patients will be followed up at 6 weeks, 6 months and 12 months and also have a Computed Tomography (CT) scan at 3 months.
Intervention code [1] 257869 0
Treatment: Devices
Comparator / control treatment
Patients in the Control Group will receive a total knee replacement using conventional methods and equipment where their implant will be positioned so that their leg is a straight line from their hip to their ankle (i.e. mechanical axis of 0 degrees). The procedure will take approximately 45 minutes.

Patients will be randomized to either the Control Group or Intervention Group and will not be told which group they have been assigned to. As a result, patients assigned to the Control Group will also need to have a pre-operative MRI scan.
Patients in the Control Group will also be followed up at 6 weeks, 6 months and 12 months, and also have a Computed Tomography (CT) scan at 3 months.
Control group
Active

Outcomes
Primary outcome [1] 261960 0
To demonstrate, through calculation of Oxford Knee Score at 12 months postoperative, that total knee replacement (TKR) performed using the ShapeMatch Cutting Guide provides improvement from preoperative levels of patient pain and function comparable to the improvement obtained with TKR performed using computer-assisted Navigation.
Timepoint [1] 261960 0
Pre-operatively and 6 weeks, 6 months and 12 months post-operatively.
Secondary outcome [1] 268880 0
The efficacy objective is to compare radiographic, pain, function and health-related quality of life (QOL) between the ShapeMatch Cutting Guide group and the computer-assisted Navigation control group. This objective will be achieved by utilizing the following instruments pre-operatively and at the 6-week, 6-month and 12 month visits:
- Perth CT protocol
- AP and ML X-rays
- The International Knee Society Score (IKSS)
- The Forgotten Joint Score (FJS-12)
- WOMAC
- EQ-5D
- VAS Pain
Timepoint [1] 268880 0
Pre-operatively and 6 weeks, 6 months and 12 months post-operatively.
Secondary outcome [2] 268881 0
To compare the cost-effectiveness and cost-utility of the procedure between the ShapeMatch Cutting Guide group and the computer-assisted Navigation control group. This objective will be assessed by recording and calculating the following parameters:
- Wound length
- Total duration of operating procedure (anaesthetic time and skin-to-skin incision time)
- Cost of consumable items used during operating procedure
- Length of stay in hospital
- Quality-adjusted life-years (QALYs) from EQ-5D
Timepoint [2] 268881 0
Intra-operatively, at hospital discharge and at 6 weeks, 6 months and 12 post-operatively.

Eligibility
Key inclusion criteria
- The patient is a male or non-pregnant female between the ages of 50-80.
- The patient requires a primary total knee replacement and is indicated for computer-assisted surgery.
- The patient has a primary diagnosis of osteoarthritis (OA).
- The patient has intact collateral ligaments.
- The patient is able to undergo MRI scanning of the affected limb.
- The patient has signed the study specific, HREC-approved, Informed Consent document.
- The patient is willing and able to comply with the specified pre-operative and post-operative clinical and radiographic evaluations.
Minimum age
40 Years
Maximum age
80 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
- Patient has had a high tibial osteotomy or femoral osteotomy.
- The patient is morbidly obese (BMI is greater than or equal to 40).
- The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
- The patient has varus or valgus malalignment greater than or equal to 15 degrees (relative to mechanical axis).
- The patient has a fixed flexion deformity greater than or equal to 15 degrees.
- The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
- The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
- The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
- Patient has a cognitive impairment, an intellectual disability or a mental illness.
- The patient is pregnant.
- The patient has metal hardware present in the region of the hip, knee or ankle (as this is known to create geometrical distortion in the region of the implant).
- The patient has any known contraindications for undergoing assessment by MRI (e.g. ferrous implants, metallic clips, magnetically activated implanted devices such as cardiac pacemakers, etc).

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Patients will be enrolled in the study after signing the informed consent form and meeting the inclusion and exclusion criteria. If participants met these criteria they will be randomised to either the Control Group or the Intervention Group.
This will be achieved via a block randomisation process. A central randomisation list will be computer generated by a consultant statistician. Once a patient has met criteria for enrolment, the Principal Investigator or designee will phone/email the Sponsor with the Initials, Date of Birth and Patient Number (assigned in ascending order at time of recruitment). A randomisation number, corresponding to a randomisation envelope held at the study site, will be provided. Once this number is received the envelope will be located and opened. The Principal Investigator will note the group allocation in the Case Report Form.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A computer will generate a randomisation sequence which will allocate each study number to either the control group or the intervention group.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
7/06/2011
Actual
4/08/2011
Date of last participant enrolment
Anticipated
Actual
7/03/2013
Date of last data collection
Anticipated
Actual
9/04/2018
Sample size
Target
100
Accrual to date
Final
100
Recruitment outside Australia
Country [1] 3142 0
New Zealand
State/province [1] 3142 0

Funding & Sponsors
Funding source category [1] 258337 0
Commercial sector/Industry
Name [1] 258337 0
Stryker Australia
Country [1] 258337 0
Australia
Primary sponsor type
Commercial sector/Industry
Name
Stryker Australia
Address
8 Herbert Street
St Leonards, Sydney
NSW 2065
Country
Australia
Secondary sponsor category [1] 257598 0
None
Name [1] 257598 0
Address [1] 257598 0
Country [1] 257598 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 260394 0
Northern X Regional Ethics Committee
Ethics committee address [1] 260394 0
Ethics committee country [1] 260394 0
New Zealand
Date submitted for ethics approval [1] 260394 0
15/03/2011
Approval date [1] 260394 0
05/05/2011
Ethics approval number [1] 260394 0
NTX/11/03/017

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 32099 0
Dr Bill Farrington
Address 32099 0
North Shore Hospital
Shakespeare Road
North Shore City
Auckland 0622
NEW ZEALAND
Country 32099 0
New Zealand
Phone 32099 0
64 21 221 4002
Fax 32099 0
Email 32099 0
[email protected]
Contact person for public queries
Name 15346 0
Simone Mclean
Address 15346 0
Clinical Research Associate II. Stryker Australia 8 Herbert Street ST LEONARDS NSW 2065
Country 15346 0
Australia
Phone 15346 0
61 2 9467 1281
Fax 15346 0
Email 15346 0
[email protected]
Contact person for scientific queries
Name 6274 0
David Fulker
Address 6274 0
Clinical Research Associate. Stryker Australia 8 Herbert Street ST LEONARDS NSW 2065
Country 6274 0
Australia
Phone 6274 0
61 2 9467 1072
Fax 6274 0
Email 6274 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.